Future Science GroupBrowse
Supplementary_table1.docx (16.33 kB)
Download file

Supplementary data: Idarucizumab (Praxbind®) for dabigatran reversal in patients undergoing heart transplantation: a cohort of 10 patients.docx

Download (16.33 kB)
dataset
posted on 2021-02-15, 20:20 authored by Eran Kalmanovich, Pascal Battistella, Philippe Rouviere, Bernard Albat, Jean-Marc Frapier, Roland Demaria, Audrey Agullo, Marc Mourad, Pascal Colson, Florence Leclercq, Philippe Gaudard, François Roubille, Fabien Huet

Supplementary Table 1. Idarucizumab (Praxbind®) for dabigatran reversal in patients undergoing heart transplantation: a cohort of 10 patients

Baseline characteristics of the patients.

History

Usage metrics

Read the peer-reviewed publication

Idarucizumab (Praxbind®) for dabigatran reversal in patients undergoing heart transplantation: a cohort of 10 patients
Future Science OAFuture Science OA

Categories

Keywords

direct oral anticoagulant (DOAC)DabigatranIdarucizumabHeart transplantationCardiology (incl. Cardiovascular Diseases)

Licence

CC BY 4.0

Exports